Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.43M Sell
11,379
-3,301
-22% -$655K 0.35% 71
2026
Q1
$2.16M Buy
14,680
+90
+0.6% +$13.2K 0.25% 85
2025
Q4
$1.77M Sell
14,590
-5,660
-28% -$664K 0.2% 92
2025
Q3
$2.18M Buy
20,250
+680
+3% +$63.4K 0.26% 84
2025
Q2
$1.75M Sell
19,570
-3,310
-14% -$249K 0.22% 85
2025
Q1
$1.56M Buy
22,880
+3,750
+20% +$270K 0.22% 86
2024
Q4
$1.21M Buy
+19,130
New +$1.29M 0.18% 103

Other funds holding KLAC

Novem Group's KLAC Position: Q2 2026 in Review

Novem Group reduced its KLA (KLAC) stake by 22% in Q2 2026, selling an estimated $655K and leaving 11,379 shares worth $3.43M. The position accounts for 0.35% of the portfolio, ranked #71.

Novem Group first reported a position in KLAC in Q4 2024 and has held it in 7 quarters since. 2,477 funds tracked by Wall St. Rank hold KLAC as of Q2 2026.

  • Novem Group held 11,379 shares of KLA worth $3.43M as of Q2 2026.
  • Novem Group sold 3,301 KLA shares in Q2 2026, an estimated $655K.
  • KLA made up 0.35% of Novem Group's portfolio in Q2 2026, its #71 holding.
  • Novem Group first reported a position in KLA in Q4 2024 and has held it in 7 quarters since.
  • 2,477 funds tracked by Wall St. Rank held KLA as of Q2 2026.

Based on Novem Group's 13F filing for Q2 2026, filed 21 Jul 2026.